<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24078930</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2013</Volume><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes' mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication.</ArticleTitle><Pagination><StartPage>965853</StartPage><MedlinePgn>965853</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">965853</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2013/965853</ELocationID><Abstract><AbstractText>It has been reported that diabetes mellitus (DM) was an epidemiologically identified risk factor for development of dengue hemorrhagic fever (DHF)/severe dengue in dengue virus (DENV) affected patients, and T helper 2 (Th2) cytokines such as interleukin-4 (IL-4) and IL-10 each plays an important role in the immunopathogenesis of DHF in studies involving general population. To better understand the relationship between these epidemiological and immunological findings, we performed an in vitro study evaluating the sequential immunological reactions and viral load in the DENV infected mononuclear cells of adults with type 2 DM (T2DM group, n = 33) and normal adults (control group, n = 29). We found in the T2DM group significantly higher IL-4 level on the first (P = 0.049) and the third (P = 0.022) postinfection days, while higher IL-10 (P = 0.042) and granulocyte-macrophage colony-stimulating factor (GM-CSF) (P = 0.009) were detected on the third postinfection day. No significant difference in DENV viral load between the cultured mononuclear cells from both groups was found on the first and third post-infection days. These data immunologically suggest that patients with T2DM are at higher risk for development of DHF/severe dengue and strengthen the previously epidemiologically identified role of DM being a predictive risk factor for progressing into DHF/severe dengue in DENV-affected patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ing-Kit</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan ; Chang Gung University Medical College, Tao-Yuan 333, Taiwan ; Infection Control Committee, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Ching-Jung</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rong-Fu</ForeName><Initials>RF</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zih-Syuan</ForeName><Initials>ZS</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chang-Mei</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chiung-Fen</ForeName><Initials>CF</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chung-Hao</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Yu</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kuender D</ForeName><Initials>KD</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jien-Wei</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C111835">CCL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>207137-56-2</RegistryNumber><NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>83869-56-1</RegistryNumber><NameOfSubstance UI="D016178">Granulocyte-Macrophage Colony-Stimulating Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016178" MajorTopicYN="N">Granulocyte-Macrophage Colony-Stimulating Factor</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015847" MajorTopicYN="N">Interleukin-4</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042541" MajorTopicYN="N">Intracellular Space</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24078930</ArticleId><ArticleId IdType="pmc">PMC3773921</ArticleId><ArticleId IdType="doi">10.1155/2013/965853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: World Health Organization; 2009.</Citation></Reference><Reference><Citation>Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Current concepts: Dengue. The New England Journal of Medicine. 2012;366(15):1423&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale Journal of Biology and Medicine. 1970;42(5):350&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2591710</ArticleId><ArticleId IdType="pubmed">5419208</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clinical Infectious Diseases. 1994;19(3):500&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pubmed">7811870</ArticleId></ArticleIdList></Reference><Reference><Citation>Rico-Hesse R, Harrison LM, Nisalak A, et al. Molecular evolution of dengue type 2 virus in Thailand. American Journal of Tropical Medicine and Hygiene. 1998;58(1):96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">9452299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey BD, Igarashi A. Severity-related molecular differences among nineteen strains of dengue type 2 viruses. Microbiology and Immunology. 2000;44(3):179&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan NT, Hirayama K. Host genetic susceptibility to severe dengue infection. Tropical Medicine and International Health. 2011;39(supplement 4):73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3317601</ArticleId><ArticleId IdType="pubmed">22500139</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I-K, Liu J-W, Yang KD. Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. American Journal of Tropical Medicine and Hygiene. 2008;79(2):149&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">18689614</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n MG, Kouri G, Bravo J, Valdes L, Susana V, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. International Journal of Infectious Diseases. 2002;6(2):118&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">12121599</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, Salim A, Lee VJ, et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Neglected Tropical Diseases. 2012;6(5, article e1641)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341340</ArticleId><ArticleId IdType="pubmed">22563519</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo MA, Rodrigues LC, Barreto ML, et al. Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Neglected Tropical Diseases. 2010;4(6, article e699)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879373</ArticleId><ArticleId IdType="pubmed">20532230</ArticleId></ArticleIdList></Reference><Reference><Citation>Limonta D, Torres G, Cap&#xf3; V, Guzm&#xe1;n MG. Apoptosis, vascular leakage and increased risk of severe dengue in a type 2 diabetes mellitus patient. Diabetes and Vascular Disease Research. 2008;5(3):213&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">18777495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo JR, Guzm&#xe1;n MG, Kouri GP. Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) Transactions of the Royal Society of Tropical Medicine and Hygiene. 1987;81(5):816&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">3450004</ArticleId></ArticleIdList></Reference><Reference><Citation>Conget I. Diagnosis, classification and pathogenesis of diabetes mellitus. Revista Espa&#xf1;ola de Cardiologia. 2002;55(5):528&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">12015934</ArticleId></ArticleIdList></Reference><Reference><Citation>Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">17187246</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolar M. Glycemic control and complications in type 2 diabetes mellitus. American Journal of Medicine. 2010;123(3):S3&#x2013;S11.</Citation><ArticleIdList><ArticleId IdType="pubmed">20206730</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunology and Medical Microbiology. 2000;28(3):183&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">10865168</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayamada S, Takahashi H, Kanno Y, O&#x2019;Shea JJ. Helper T cell diversity and plasticity. Current Opinion in Immunology. 2012;24(3):297&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383341</ArticleId><ArticleId IdType="pubmed">22341735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today. 1996;17(3):138&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">8820272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi UC, Elbishbishi EA, Agarwal R, et al. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. Journal of Medical Virology. 1999;59(3):335&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">10502266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R-F, Liu J-W, Yeh W-T, et al. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunology and Medical Microbiology. 2005;44(1):43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">15780577</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R-F, Yang KD, Wang L, Liu J-W, Chiu C-C, Cheng J-T. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2007;101(11):1106&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pubmed">17764712</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Vaughn DW, Kalayanarooj S, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. Journal of Medical Virology. 1999;59(3):329&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">10502265</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh W-T, Chen R-F, Wang L, Liu J-W, Shaio M-F, Yang KD. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunology and Medical Microbiology. 2006;48(1):84&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">16965355</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen J, Koraka P, Velzing J, Copra C, Osterhaus ADME. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clinical and Diagnostic Laboratory Immunology. 2000;7(6):867&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC95976</ArticleId><ArticleId IdType="pubmed">11063489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R-F, Yeh W-T, Yang M-Y, Yang KD. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunology and Medical Microbiology. 2001;30(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11172984</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KD, Wang C-L, Shaio M-F. Production of cytokines and platelet activating factor in secondary dengue virus infections. Journal of Infectious Diseases. 1995;172(2):604&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">7622917</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer DR, Sun P, Celluzzi C, et al. Differential effects of dengue virus on infected and bystander dendritic cells. Journal of Virology. 2005;79(4):2432&#x2013;2439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC546567</ArticleId><ArticleId IdType="pubmed">15681444</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang T-H, Chen S-R, Yu C-Y, et al. Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-&#x3ba;B activation to downregulate cytokine production. PLoS One. 2012;7(8, article e41635)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3425550</ArticleId><ArticleId IdType="pubmed">22927911</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. Journal of Virology. 2001;75(8):3501&#x2013;3508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC114841</ArticleId><ArticleId IdType="pubmed">11264339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comparative Immunology, Microbiology and Infectious Diseases. 2007;30(5-6):329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">17645944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y-R, Liu M-T, Lei H-Y, et al. MCP1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. Journal of General Virology. 2006;87(12):3623&#x2013;3630.</Citation><ArticleIdList><ArticleId IdType="pubmed">17098977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernasconi S, Matteucci C, Sironi M, et al. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. International Journal of Cancer. 1995;60(3):300&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">7829234</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver KG, Kettman JR, Fulton RJ. Multiplexed analysis of human cytokines by use of the flowmetrix system. Clinical Chemistry. 1998;44(9):2057&#x2013;2060.</Citation><ArticleIdList><ArticleId IdType="pubmed">9733011</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C-Y, Lee I-K, Lee C-H, Yang KD, Liu J-W. Comparisons of dengue illness classified based on the 1997 and 2009 World Health Organization dengue classification schemes. Journal of Microbiology, Immunology and Infection. 2013;46(4):271&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">23022142</ArticleId></ArticleIdList></Reference><Reference><Citation>Spellberg B, Edwards JE., Jr. Type 1/type 2 immunity in infectious diseases. Clinical Infectious Diseases. 2001;32(1):76&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">11118387</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Endy TP, Houng H-SH, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. Journal of Infectious Diseases. 2002;185(9):1213&#x2013;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">12001037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W-K, Chao D-Y, Kao C-L, et al. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003;305(2):330&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">12573578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Molecular Medicine. 2008;14(3-4):222&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2215762</ArticleId><ArticleId IdType="pubmed">18235842</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernasconi S, Matteucci C, Sironi M, et al. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. International Journal of Cancer. 1995;60(3):300&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">7829234</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza FA, Cruz OG, Zagne SM, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infectious Diseases. 2008;8, article 86</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2474613</ArticleId><ArticleId IdType="pubmed">18578883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>